TimesSquare Capital Management LLC Grows Stock Position in Addus HomeCare Co. (NASDAQ:ADUS)

TimesSquare Capital Management LLC raised its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 2.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 276,915 shares of the company’s stock after buying an additional 6,490 shares during the quarter. TimesSquare Capital Management LLC owned approximately 1.53% of Addus HomeCare worth $36,838,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Point72 Asset Management L.P. grew its holdings in shares of Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after purchasing an additional 315,602 shares during the period. Millennium Management LLC grew its stake in Addus HomeCare by 412.7% during the second quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock worth $36,739,000 after buying an additional 254,705 shares during the period. Boston Partners acquired a new stake in shares of Addus HomeCare in the first quarter worth $12,215,000. Ghisallo Capital Management LLC purchased a new position in shares of Addus HomeCare in the 2nd quarter valued at $11,611,000. Finally, Lord Abbett & CO. LLC acquired a new position in shares of Addus HomeCare during the 1st quarter valued at $8,274,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

ADUS opened at $127.58 on Friday. The company has a market cap of $2.31 billion, a PE ratio of 29.19, a price-to-earnings-growth ratio of 2.30 and a beta of 1.04. The stock has a 50-day moving average of $129.60 and a 200-day moving average of $121.40. Addus HomeCare Co. has a 52-week low of $81.51 and a 52-week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.03 EPS. On average, research analysts predict that Addus HomeCare Co. will post 4.57 earnings per share for the current year.

Insider Buying and Selling at Addus HomeCare

In related news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the sale, the director now owns 3,366 shares of the company’s stock, valued at $429,165. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 22,917 shares of company stock valued at $3,050,082 in the last quarter. Corporate insiders own 4.60% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on ADUS shares. Stephens upped their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday. KeyCorp began coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. Royal Bank of Canada dropped their price target on shares of Addus HomeCare from $141.00 to $136.00 and set an “outperform” rating on the stock in a research note on Wednesday. Oppenheimer upped their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Finally, TD Cowen lifted their target price on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Addus HomeCare currently has a consensus rating of “Moderate Buy” and an average price target of $131.63.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.